KLB and hepatocellular carcinoma: We postulated that RNAi-mediated silencing of KLB or FGFR4 eliminated the bulk hepatoma population exhibiting hyper-activated FGFR4 signaling and AFP secretion, thereby resulting in an overall decrease in AFP protein levels shown in Figure 4A.